For tobacco harm reduction to succeed, adult smokers who don't or can't quit should be encouraged to transition to FDA-authorized less harmful products.

With FDA regulation fully in place, the agency can and should provide adult smokers with access to products that the science demonstrates are "appropriate for the protection of public health." The FDA is also empowered to authorize the communication of health claims to adult smokers, as long as the science supports it.

FDA's regulatory pathways are essential for the transformation of this industry over the long term – and we engage extensively with policy makers and other stakeholders at every level to help create awareness of the FDA's central role in providing adult smokers with potentially less harmful product options.

Phil Park Photo

We regularly engage with federal policy makers to educate them on harm reduction, innovative new tobacco products, and the FDA's review of reduced-harm products. Phil Park our Vice President of Federal Government Affairs explains more here.


View Other Public Policy Positions